References
- Tally, J. J. Prog. Med. Chem. 1999, 36, 201. https://doi.org/10.1016/S0079-6468(08)70048-1
- Herrero, J. F.; Romero-Sandoval, E. A.; Gaitan, G.; Mazario, J. CNS Drug Rev. 2003, 9, 227. https://doi.org/10.1111/j.1527-3458.2003.tb00251.x
- Akaogi, J.; Nozaki, T.; Satoh, M.; Yamada, H. Endocr. Metab. Immune. Disord. Drug Targets 2006, 6, 383. https://doi.org/10.2174/187153006779025711
- Blazovics, A.; Hagymási, K.; Prónai, L. Orv. Hetil. 2004, 145, 2523.
- Moon, J. T.; Jeon, J. Y.; Park, H. A.; Noh, Y.-S.; Lee, K.-T.; Kim, J.; Choo, D. J.; Lee, J. Y. Bioorg. Med. Chem. Lett. 2010, 20, 734. https://doi.org/10.1016/j.bmcl.2009.11.067
- Klebe, G.; Abraham, U.; Meitzner, T. J. Med. Chem. 1994, 37, 4130. https://doi.org/10.1021/jm00050a010
- Klebe, G.; Abraham, U. J. Comput.-Aided Mol. Design 1999, 13, 1. https://doi.org/10.1023/A:1008047919606
- Bohm, M.; Sturzebecher, J.; Klebe, G. J. Med. Chem. 1999, 42, 458. https://doi.org/10.1021/jm981062r
- SYBYL-X 1.2, Tripos Inc., 1699 Hanley Road, St. Louis, MO 63144.
- Clark, M.; Cramer, R. D., III; Van Opdenbosch, N. J. Comput. Chem. 1989, 10, 982. https://doi.org/10.1002/jcc.540100804
- Crammer, R. D., III; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959. https://doi.org/10.1021/ja00226a005
Cited by
- Molecular Docking and 3D QSAR Research of Indolocarbazole Series as Cyclin-Dependent Kinase Inhibitors vol.59, pp.7, 2012, https://doi.org/10.1134/s0022476618070065